AI Summary
Thinking
Thinking
We reviewed 3 live results for exomextra and narrowed them down to the 3 options that look most worth comparing first.
The options are ExomeXtra®, Single ExomeXtra® and ExomeXtra® Sequencing.
Source: CeGaT GmbH
Description
ExomeXtra® is an advanced exome sequencing and diagnostic enrichment service developed by CeGaT GmbH. Expanding beyond conventional coding-region sequencing, version 6 incorporates disease-associated non-coding variants across more than 46,000 targeted regions, non-coding splice sites, and small nuclear RNAs including RNU4-2 for neurodevelopmental disorders. It also features prenatal screening for non-genetic infections like toxoplasmosis and cytomegalovirus, an enhanced genomic backbone for array-like copy number variation detection, and coverage of repeat expansions linked to neuromuscular conditions.
Best for
geneticists, clinicians, genetic disease diagnostics and prenatal infection screening
Rate this product
Source: CeGaT GmbH
Description
Single ExomeXtra is a genetic diagnostic test developed by CeGaT for patients with complex, heterogeneous, or unspecific symptoms when parental samples are unavailable. It combines whole exome sequencing, whole genome coverage for disease-relevant regions, and array-CGH resolution copy-number variant detection in a single test. The comprehensive analysis covers coding regions, non-coding disease-associated regions, mitochondrial genome, and mosaic variants, delivering an interdisciplinary medical report with clinical management recommendations within three to four weeks.
Best for
Physicians and geneticists, Patients with complex, heterogeneous, or unspecific symptoms without parental samples, Diagnosis of rare or undiagnosed genetic diseases and Single-individual exome diagnostics when parental samples are unavailable
Rate this product
Source: CeGaT GmbH
Description
ExomeXtra® Sequencing by CeGaT GmbH is a next-generation sequencing service combining whole exome sequencing with targeted non-coding disease-relevant variants, copy number variation analysis, and pathogen genome detection. Performed on Illumina platforms in an accredited laboratory in Tübingen, Germany, the workflow covers library preparation, paired-end sequencing, bioinformatic analysis via Illumina DRAGEN, and structured project reporting with FASTQ deliverables in typically 15 days for research and clinical studies.
Best for
Genetic researchers, Physicians, Human disease mutation discovery and Copy number variation analysis
Rate this product
| Compare | #1ExomeXtra® | #2Single ExomeXtra® | #3ExomeXtra® Sequencing |
|---|---|---|---|
| Source | CeGaT GmbH | CeGaT GmbH | CeGaT GmbH |
| Description | ExomeXtra® is an advanced exome sequencing and diagnostic enrichment service developed by CeGaT GmbH. Expanding beyond conventional coding-region sequencing, version 6 incorporates disease-associated non-coding variants across more than 46,000 targeted regions, non-coding splice sites, and small nuclear RNAs including RNU4-2 for neurodevelopmental disorders. It also features prenatal screening for non-genetic infections like toxoplasmosis and cytomegalovirus, an enhanced genomic backbone for array-like copy number variation detection, and coverage of repeat expansions linked to neuromuscular conditions. | Single ExomeXtra is a genetic diagnostic test developed by CeGaT for patients with complex, heterogeneous, or unspecific symptoms when parental samples are unavailable. It combines whole exome sequencing, whole genome coverage for disease-relevant regions, and array-CGH resolution copy-number variant detection in a single test. The comprehensive analysis covers coding regions, non-coding disease-associated regions, mitochondrial genome, and mosaic variants, delivering an interdisciplinary medical report with clinical management recommendations within three to four weeks. | ExomeXtra® Sequencing by CeGaT GmbH is a next-generation sequencing service combining whole exome sequencing with targeted non-coding disease-relevant variants, copy number variation analysis, and pathogen genome detection. Performed on Illumina platforms in an accredited laboratory in Tübingen, Germany, the workflow covers library preparation, paired-end sequencing, bioinformatic analysis via Illumina DRAGEN, and structured project reporting with FASTQ deliverables in typically 15 days for research and clinical studies. |
| Best for | geneticists, clinicians, genetic disease diagnostics and prenatal infection screening | Physicians and geneticists, Patients with complex, heterogeneous, or unspecific symptoms without parental samples, Diagnosis of rare or undiagnosed genetic diseases and Single-individual exome diagnostics when parental samples are unavailable | Genetic researchers, Physicians, Human disease mutation discovery and Copy number variation analysis |
| Action | CeGaT GmbH | CeGaT GmbH | CeGaT GmbH |
| Rate this product |
"ExomeXtra® from CeGaT GmbH."
Note: TopFind AI compiles product and service information for general comparison purposes only.